170 related articles for article (PubMed ID: 33579322)
1. Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale.
Patterson MC; Lloyd-Price L; Guldberg C; Doll H; Burbridge C; Chladek M; íDali C; Mengel E; Symonds T
Orphanet J Rare Dis; 2021 Feb; 16(1):79. PubMed ID: 33579322
[TBL] [Abstract][Full Text] [Related]
2. Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study.
Mengel E; Bembi B; Del Toro M; Deodato F; Gautschi M; Grunewald S; Grønborg S; Héron B; Maier EM; Roubertie A; Santra S; Tylki-Szymanska A; Day S; Symonds T; Hudgens S; Patterson MC; Guldberg C; Ingemann L; Petersen NHT; Kirkegaard T; Í Dali C
Orphanet J Rare Dis; 2020 Nov; 15(1):328. PubMed ID: 33228797
[TBL] [Abstract][Full Text] [Related]
3. International consensus on clinical severity scale use in evaluating Niemann-Pick disease Type C in paediatric and adult patients: results from a Delphi Study.
Evans W; Patterson M; Platt F; Guldberg C; Mathieson T; Pacey J;
Orphanet J Rare Dis; 2021 Nov; 16(1):482. PubMed ID: 34794481
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment.
Mengel E; Patterson MC; Da Riol RM; Del Toro M; Deodato F; Gautschi M; Grunewald S; Grønborg S; Harmatz P; Héron B; Maier EM; Roubertie A; Santra S; Tylki-Szymanska A; Day S; Andreasen AK; Geist MA; Havnsøe Torp Petersen N; Ingemann L; Hansen T; Blaettler T; Kirkegaard T; Í Dali C
J Inherit Metab Dis; 2021 Nov; 44(6):1463-1480. PubMed ID: 34418116
[TBL] [Abstract][Full Text] [Related]
5. A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.
Fields T; Patterson M; Bremova-Ertl T; Belcher G; Billington I; Churchill GC; Davis W; Evans W; Flint S; Galione A; Granzer U; Greenfield J; Karl R; Kay R; Lewi D; Mathieson T; Meyer T; Pangonis D; Platt FM; Tsang L; Verburg C; Factor M; Strupp M
Trials; 2021 Jan; 22(1):84. PubMed ID: 33482890
[TBL] [Abstract][Full Text] [Related]
6. Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective.
Mengel E; Patterson MC; Chladek M; Guldberg C; Í Dali C; Symonds T; Lloyd-Price L; Mathieson T; Crowe J; Burbridge C
Orphanet J Rare Dis; 2021 Nov; 16(1):493. PubMed ID: 34819124
[TBL] [Abstract][Full Text] [Related]
7. Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial.
Sharma R; Hastings C; Staretz-Chacham O; Raiman J; Paucar M; Spiegel R; Murray B; Hurst B; Liu B; Kjems L; Hrynkow S
Mol Genet Metab Rep; 2023 Sep; 36():100988. PubMed ID: 37670901
[TBL] [Abstract][Full Text] [Related]
8. Trial of
Bremova-Ertl T; Ramaswami U; Brands M; Foltan T; Gautschi M; Gissen P; Gowing F; Hahn A; Jones S; Kay R; Kolnikova M; Arash-Kaps L; Marquardt T; Mengel E; Park JH; Reichmannová S; Schneider SA; Sivananthan S; Walterfang M; Wibawa P; Strupp M; Martakis K
N Engl J Med; 2024 Feb; 390(5):421-431. PubMed ID: 38294974
[TBL] [Abstract][Full Text] [Related]
9. Consistently High Agreement Between Independent Raters of Niemann-Pick Type C1 Clinical Severity Scale in Phase 2/3 Trial.
Farhat N; Bailey L; Friedmann K; Bushnell DM; Rodriguez D; Berry-Kravis E; Porter FD
Pediatr Neurol; 2022 Feb; 127():32-38. PubMed ID: 34952292
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study.
Fields T; M Bremova T; Billington I; Churchill GC; Evans W; Fields C; Galione A; Kay R; Mathieson T; Martakis K; Patterson M; Platt F; Factor M; Strupp M
Trials; 2023 May; 24(1):361. PubMed ID: 37248494
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-β-Cyclodextrin.
Berry-Kravis E; Chin J; Hoffmann A; Winston A; Stoner R; LaGorio L; Friedmann K; Hernandez M; Ory DS; Porter FD; O'Keefe JA
Pediatr Neurol; 2018 Mar; 80():24-34. PubMed ID: 29429782
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
13. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.
Yanjanin NM; Vélez JI; Gropman A; King K; Bianconi SE; Conley SK; Brewer CC; Solomon B; Pavan WJ; Arcos-Burgos M; Patterson MC; Porter FD
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):132-40. PubMed ID: 19415691
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.
Bremova-Ertl T; Claassen J; Foltan T; Gascon-Bayarri J; Gissen P; Hahn A; Hassan A; Hennig A; Jones SA; Kolnikova M; Martakis K; Raethjen J; Ramaswami U; Sharma R; Schneider SA
J Neurol; 2022 Mar; 269(3):1651-1662. PubMed ID: 34387740
[TBL] [Abstract][Full Text] [Related]
15. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus.
Vernon MK; Swett LL; Speck RM; Munera C; Spencer RH; Wen W; Menzaghi F
J Patient Rep Outcomes; 2021 Dec; 5(1):134. PubMed ID: 34952964
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph.
El-Masri S; Malpas CB; Evans A; Walterfang M
Neurol Sci; 2022 Nov; 43(11):6339-6347. PubMed ID: 35945383
[TBL] [Abstract][Full Text] [Related]
17. Preliminary development of proxy-rated quality-of-life scales for children and adults with Niemann-Pick type C.
Aston L; Shaw R; Knibb R
Qual Life Res; 2019 Nov; 28(11):3083-3092. PubMed ID: 31227959
[TBL] [Abstract][Full Text] [Related]
18. Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials.
Cortina-Borja M; Te Vruchte D; Mengel E; Amraoui Y; Imrie J; Jones SA; I Dali C; Fineran P; Kirkegaard T; Runz H; Lachmann R; Bremova-Ertl T; Strupp M; Platt FM
Orphanet J Rare Dis; 2018 Aug; 13(1):143. PubMed ID: 30115089
[TBL] [Abstract][Full Text] [Related]
19. The experience of living with Niemann-Pick type C: a patient and caregiver perspective.
Golden E; van Gool R; Cay M; Goodlett B; Cao A; Al-Hertani W; Upadhyay J
Orphanet J Rare Dis; 2023 May; 18(1):120. PubMed ID: 37210540
[TBL] [Abstract][Full Text] [Related]
20. Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia.
Habtamu K; Alem A; Medhin G; Fekadu A; Dewey M; Prince M; Hanlon C
Health Qual Life Outcomes; 2017 Apr; 15(1):64. PubMed ID: 28381230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
